These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24252343)

  • 1. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iTRAQ-based quantitative proteomics study on the neuroprotective effects of extract of Acanthopanax senticosus harm on SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu SM; Lu F
    Neurochem Int; 2014 Jun; 72():37-47. PubMed ID: 24795107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acanthopanax senticosus Protects Structure and Function of Mesencephalic Mitochondria in A Mouse Model of Parkinson's Disease.
    Liu SM; Li XZ; Zhang SN; Yang ZM; Wang KX; Lu F; Wang CZ; Yuan CS
    Chin J Integr Med; 2018 Nov; 24(11):835-843. PubMed ID: 30090975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice.
    Liu SM; Li XZ; Huo Y; Lu F
    Phytomedicine; 2012 May; 19(7):631-8. PubMed ID: 22402244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
    Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral potential biomarkers discovery and metabolic pathways analysis of α-synucleinopathies and the dual effects of Acanthopanax senticosus Harms on central nervous system through metabolomics analysis.
    Zhang SN; Li XZ; Lu F; Liu SM
    J Ethnopharmacol; 2015 Apr; 163():264-72. PubMed ID: 25660332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
    Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
    Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated proteomics and metabolomics reveals metabolism disorders in the α-syn mice and potential therapeutic effect of Acanthopanax senticosus extracts.
    Fu J; Gao X; Lu Y; Lu F; Wang Y; Chen P; Wang C; Yuan C; Liu S
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116878. PubMed ID: 37419226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats.
    Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X
    J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral metabonomics study on Parkinson's disease mice treated with extract of Acanthopanax senticosus harms.
    Li XZ; Zhang SN; Lu F; Liu CF; Wang Y; Bai Y; Wang N; Liu SM
    Phytomedicine; 2013 Oct; 20(13):1219-29. PubMed ID: 23830815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
    Choong CJ; Say YH
    Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.
    Kim S; Lim J; Bang Y; Moon J; Kwon MS; Hong JT; Jeon J; Seo H; Choi HJ
    Mol Neurobiol; 2018 Feb; 55(2):1607-1619. PubMed ID: 28190238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
    Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
    Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
    Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
    Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray Expression Analysis for the Paradoxical Roles of Acanthopanax senticosus Harms in Treating α-Synucleinopathies.
    Li XZ; Zhang SN; Lu F; Liu SM
    Phytother Res; 2016 Feb; 30(2):243-52. PubMed ID: 26612828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.